Lotus Eye Hospital net profit rises 13% in Q1FY27 on revenue surge
Lotus Eye Hospital posted a 12.6% increase in Q1FY27 net profit to ₹61.37 lakh, aided by a 26.2% revenue jump to ₹1,705.71 lakh. Despite a 38.4% rise in pre-tax profits, higher finance costs and deferred tax expenses constrained bottom-line growth.
*this image is generated using AI for illustrative purposes only.
Lotus Eye Hospital reported a 12.6% year-on-year increase in net profit to ₹61.37 lakh for the quarter ended June 30, 2026, driven by a robust 26.2% surge in revenue from operations to ₹1,705.71 lakh. The Coimbatore-based eye care provider’s strong top-line growth signals sustained demand recovery and operational scaling, although rising finance costs and deferred tax expenses moderated bottom-line retention compared to pre-tax profits.
The Board of Directors approved the standalone unaudited financial results at a meeting held on August 10, 2026, pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, Anbarasu & Jalapathi Chartered Accountants. Newspaper advertisements regarding the results were published on August 11, 2026, in Business Standard and The Tamil Hindu.
Financial Performance
Total income rose to ₹1,726.79 lakh from ₹1,370.45 lakh in Q1FY26, supported by increased patient footfall and service utilization. While other income declined slightly to ₹21.08 lakh from ₹18.76 lakh, core operational revenue drove the expansion. Profit before tax improved significantly by 38.4% to ₹101.02 lakh, reflecting better cost management relative to revenue growth. However, net profit growth was tempered by higher tax expenses, which stood at ₹39.65 lakh compared to ₹18.50 lakh in the prior year quarter, including deferred tax expenses.
| Metric | Q1FY27 (₹ in lakhs) | Q1FY26 (₹ in lakhs) | Change |
|---|---|---|---|
| Revenue from operations | 1,705.71 | 1,351.69 | +26.2% |
| Total Income | 1,726.79 | 1,370.45 | +26.0% |
| Total Expenses | 1,625.44 | 1,297.74 | +25.2% |
| Profit Before Tax | 101.02 | 72.98 | +38.4% |
| Net Profit | 61.37 | 54.48 | +12.6% |
Expense Breakdown
Operational costs scaled with revenue, with employee benefit expenses rising to ₹364.89 lakh from ₹284.38 lakh, and service expenses increasing to ₹324.82 lakh from ₹261.20 lakh. Finance costs more than quadrupled to ₹50.65 lakh from ₹11.76 lakh, likely due to new borrowings or interest rate adjustments. This increase was partially offset by lower other expenses at ₹232.38 lakh versus ₹239.85 lakh. Depreciation and amortization expenses nearly doubled to ₹163.54 lakh, indicating capital expenditure deployment.
What the Numbers Show
The divergence between the 38.4% rise in pre-tax profits and the 12.6% rise in net profit highlights the impact of tax structuring and deferred tax liabilities on final earnings. While operational efficiency improved—evidenced by total expenses growing at a similar pace to revenue—the significant jump in finance costs suggests increased leverage or debt servicing obligations that warrant monitoring in subsequent quarters. The company’s ability to maintain margin stability despite higher interest outlays demonstrates resilient core operations in the eye care segment.
Historical Stock Returns for Lotus Eye Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.07% | -5.63% | -7.24% | -1.08% | -6.71% | +149.71% |
What specific capital projects or expansions are driving the near-doubling of depreciation and amortization expenses, and when are they expected to yield ROI?
How will the quadrupling of finance costs impact the company's debt-to-equity ratio and future borrowing capacity in the coming quarters?
Will management take steps to optimize tax structuring to reduce deferred tax liabilities and improve net profit retention in FY27?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
